American Journal of Clinical Dermatology

, Volume 5, Issue 6, pp 459–462 | Cite as

Acne and its Management Beyond the Age of 35 Years

Practical Dermatology

Abstract

Although acne is not usually considered to be a disorder that affects the elderly, the disorder occurs sufficiently often in mature individuals to be noteworthy. The variety known as ‘persisting acne’ is, as its name suggests, ordinary acne that continues into adult life. ‘Chin acne’ is a curious type that occurs premenstrually in mature women, while ‘sporadic acne’ describes the sudden development of significant acne in later life for no apparent reason.

When acne develops in an individual outside the usual susceptible age group precipitating causes such as exposure to comedogenic substances or drugs must be excluded. Similarly, endocrine causes such as androgen-secreting tumors and the administration of anabolic steroids need to be considered.

All inflammatory processes are decreased in the elderly and this may be one reason for the persistence and intransigence of acne lesions in older age groups.

The principles of treatment of acne in the elderly do not differ from those in other age groups, although the emphasis during counseling needs to focus on explanation and reassurance rather than prognosis. Topical retinoids and benzoyl peroxide easily irritate elderly skin, so azelaic acid and even sulfur preparations are preferable. Low-dose systemic isotretinoin is reported to be helpful to patients in this age group and is certainly worth a trial.

References

  1. 1.
    Allam SG. Acne vulgaris in the sixth decade and beyond [MSc thesis]. Cardiff: University of Wales, 1991Google Scholar
  2. 2.
    Cunliffe WJ, Shuster SG. Pathogenesis of acne. Lancet 1969 Apr; 1 (7597): 685–7PubMedCrossRefGoogle Scholar
  3. 3.
    Kligman AM, Balin AK. Aging of human skin. In: Balin AK, Kligman AM, editors. Aging and the skin. New York: Raven Press, 1988: 1–4Google Scholar
  4. 4.
    Seukeran DC, Cunliffe WJ. Acne vulgaris in the elderly: the response to low dose isotretinoin. Br J Dermatol 1998; 139: 99–101PubMedCrossRefGoogle Scholar
  5. 5.
    Grange F, Mitschler A, Genestier S, et al. Severe pruriginous acne in dialysed renal failure: diagnostic difficulties and efficacy of isotretinoin [in French]. Am Dermatol Venerol 2001; 128: 1215–9Google Scholar
  6. 6.
    Thiboutot D, Archer DF, Lenacy A, et al. A randomised controlled trial of a low dose contraceptive containing 20 milligram of ethinyl oestradiol and 100 microgram of levonorgestrel for treatment. Fertil Steril 2001; 76: 467–8CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  1. 1.Cardiff UniversityCardiffUK

Personalised recommendations